These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4735416)

  • 1. Influence of chlorpromazine on brain serotonin turnover and body temperature in isolated aggressive mice.
    Goldberg ME; Dubnick B; Hefner M; Salama AI
    Neuropharmacology; 1973 Mar; 12(3):249-60. PubMed ID: 4735416
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of brain monoamine and locomotor activity in rats.
    Foldes A; Costa E
    Biochem Pharmacol; 1975 Sep; 24(17):1617-21. PubMed ID: 1191320
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain amine content and functional maturity in the fowl: the effects of pargyline.
    Watts JS; Mendez HC; Reilly JF; Krop S
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):130-6. PubMed ID: 5353467
    [No Abstract]   [Full Text] [Related]  

  • 4. Actions of atropine, hemicholinium-3, and physostigmine on chlorpromazine-induced changes in rat brain monoamines.
    Bhatnagar SP
    Can J Physiol Pharmacol; 1974 Jun; 52(3):500-7. PubMed ID: 4152758
    [No Abstract]   [Full Text] [Related]  

  • 5. The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):65-83. PubMed ID: 4775865
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effects of tranylcypromine and pargyline on indoleamines in brain.
    Tabakoff B; Moses F
    Biochem Pharmacol; 1976 Dec; 25(23):2555-60. PubMed ID: 985576
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the monoamine oxidase of monkey brain.
    Oommen A; Balasubramanian AS
    J Neurochem; 1977 Mar; 28(3):645-54. PubMed ID: 16088
    [No Abstract]   [Full Text] [Related]  

  • 10. Spontaneous peripheral leakage of pargyline on intracerebroventricular administration.
    Ali B; Parmar SS; Seth PK; Brumleve SJ
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1083-6. PubMed ID: 4760882
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity.
    Abeles RH; Tashjian AH
    Biochem Pharmacol; 1975 Jan; 24(2):307-8. PubMed ID: 1111545
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissociation of morphine tolerance and dependence from brain serotonin synthesis rate in mice.
    Schechter PJ; Lovenberg W; Sjoerdsma A
    Biochem Pharmacol; 1972 Mar; 21(5):751-3. PubMed ID: 5063173
    [No Abstract]   [Full Text] [Related]  

  • 14. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
    Garrick NA; Murphy DL
    Psychopharmacology (Berl); 1980; 72(1):27-33. PubMed ID: 6781004
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine oxidase dependent labeling in vivo of mouse brain by 14C-serotonin.
    Alivisatos SG; Ungar F; Parmar SS; Seth PK
    Biochem Pharmacol; 1968 Sep; 17(9):1993-5. PubMed ID: 5688280
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of some MAO inhibitors and neuroleptics on enzymes concerned in GABA metabolism.
    Simánĕ Z; Kraus P
    Act Nerv Super (Praha); 1968 Oct; 10(3):331. PubMed ID: 4387433
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of tetrahydro-beta-carbolines on monoamine oxidase and serotonin uptake in mouse brain.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1976 Oct; 25(20):2319-31. PubMed ID: 985563
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of age on the recovery of cardiac monoamine oxidase after irreversible inhibition.
    Horita A
    Biochem Pharmacol; 1968 Oct; 17(10):2091-6. PubMed ID: 5696878
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.